Page 882 - Read Online

Feier. Hepatoma Res 2020;6:75 I http://dx.doi.org/10.20517/2394-5079.2020.68 Page 5 of 5

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Kwong A, Kim WR, Lake JR, et al. OPTN/SRTR 2018 annual data report: liver. Am J Transplant 2020;20 Suppl s1:193-299.
2. Umeshita K, Eguchi S, Egawa H, et al. Liver transplantation in Japan: registry by the japanese liver transplantation society. Hepatol Res
2019;49:964-80.
3. Lee JH, Cho Y, Kim HY, et al. Serum tumor markers provide refined prognostication in selecting liver transplantation candidate for
hepatocellular carcinoma patients beyond the Milan Criteria. Ann Surg 2016;263:842-50.
4. Bhatti ABH, Dar FS, Qureshi AI, et al. Living donor liver transplantation for hepatocellular carcinoma: a single-center experience from
Pakistan. J Clin Exp Hepatol 2019;9:704-9.
5. Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant 2019;24:131-7.
6. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with
cirrhosis. N Engl J Med 1996;334:693-9.
7. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on
preoperative imaging. Am J Transplant 2007;7:2587-96.
8. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond
the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009;10:35-43.
9. Toso C, Meeberg G, Hernandez-Alejandro R, et al. Total tumor volume and alpha-fetoprotein for selection of transplant candidates with
hepatocellular carcinoma: a prospective validation. Hepatology 2015;62:158-65.
10. Shimamura T, Akamatsu N, Fujiyoshi M, et al; Japanese Liver Transplantation Society. Expanded living-donor liver transplantation
criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.
Transpl Int 2019;32:356-68.
11. Choi HJ, Kim DG, Na GH, Hong TH, You YK. Extended criteria for living donor liver transplantation in patients with advanced
hepatocellular carcinoma. Transplant Proc 2012;44:399-402.
12. Levi Sandri GB, Rayar M, Qi X, Lucatelli P. Liver transplant for patients outside Milan criteria. Transl Gastroenterol Hepatol 2018;3:81.
13. Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver
transplantation. Liver Transpl 2007;13:1637-44.
14. Taketomi A, Sanefuji K, Soejima Y, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular
carcinoma after living donor liver transplantation. Transplantation 2009;87:531-7.
15. Chang Y, Cho Y, Lee JH, et al. Comparison of models for tumor recurrence after liver transplantation for the patients with hepatocellular
carcinoma: a multicenter long-term follow-up study. Cancers 2019;11:1295.
16. Limkemann AJP, Abreu P, Sapisochin G. How far can we go with hepatocellular carcinoma in living donor liver transplantation? Curr
Opin Organ Transplant 2019;24:644-50.
17. Fisher RA, Kulik LM, Freise CE, et al; A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and
deceased donor liver transplantation. Am J Transplant 2007;7:1601-8.
18. Zhang HM, Shi YX, Sun LY, Zhu ZJ. Hepatocellular carcinoma recurrence in living and deceased donor liver transplantation: a systematic
review and meta-analysis. Chin Med J 2019;132:1599-609.
19. Goldaracena N, Gorgen A, Doyle A, et al. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased
survival vs. deceased donation. J Hepatol 2019;70:666-73.
20. Sugawara Y. Living-donor liver transplantation for patients with hepatocellular carcinoma in Japan: current situations and challenge.
Hepatobiliary Pancreat Dis Int 2020;19:1-2.